Clinical trials
Phase 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in Czechia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 4 |
| Active, not recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| Amgen | 2 |
| Bristol-Myers Squibb | 2 |
| Ascentage Pharma Group Inc. | 1 |
| Charite University, Berlin, Germany | 1 |
| Children's Oncology Group | 1 |
| Martin Schrappe | 1 |
| Novartis Pharmaceuticals | 1 |
| Pfizer | 1 |
| Princess Maxima Center for Pediatric Oncology | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 16 |
| Burkitt Lymphoma | 3 |
| Leukemia | 3 |
| Leukemia, Biphenotypic, Acute | 3 |
| Leukemia, Myeloid, Accelerated Phase | 3 |
| Lymphoma | 3 |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Recurrence | 3 |
| Blast Crisis | 2 |
| Dendritic Cell Sarcoma, Interdigitating | 2 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.